STUHEC, Matej, M. HAHN, Ivana TAŠKOVÁ, I. BAYRAKTAR, I. FITZGERALD, L. MOLITSCHNIG, A. TATAREVIC, N. LINDNER, L. AGNOLETTO a F. DA COSTA. Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. NETHERLANDS: SPRINGER, 2023, roč. 45, č. 5, s. 1286-1292. ISSN 2210-7703. Dostupné z: https://dx.doi.org/10.1007/s11096-023-01643-4. |
Další formáty:
BibTeX
LaTeX
RIS
@article{2376757, author = {Stuhec, Matej and Hahn, M. and Tašková, Ivana and Bayraktar, I. and Fitzgerald, I. and Molitschnig, L. and Tatarevic, A. and Lindner, N. and Agnoletto, L. and da Costa, F.}, article_location = {NETHERLANDS}, article_number = {5}, doi = {http://dx.doi.org/10.1007/s11096-023-01643-4}, keywords = {Clinical pharmacist interventions; Clinical pharmacy in mental health; European society of clinical pharmacy; Mental illnesses and pharmacy; Pharmaceutical services in mental health; Polypharmacy and clinical pharmacy; Psychotropics and clinical pharmacy}, language = {eng}, issn = {2210-7703}, journal = {INTERNATIONAL JOURNAL OF CLINICAL PHARMACY}, title = {Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health}, url = {https://link.springer.com/article/10.1007/s11096-023-01643-4}, volume = {45}, year = {2023} }
TY - JOUR ID - 2376757 AU - Stuhec, Matej - Hahn, M. - Tašková, Ivana - Bayraktar, I. - Fitzgerald, I. - Molitschnig, L. - Tatarevic, A. - Lindner, N. - Agnoletto, L. - da Costa, F. PY - 2023 TI - Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health JF - INTERNATIONAL JOURNAL OF CLINICAL PHARMACY VL - 45 IS - 5 SP - 1286-1292 EP - 1286-1292 PB - SPRINGER SN - 22107703 KW - Clinical pharmacist interventions KW - Clinical pharmacy in mental health KW - European society of clinical pharmacy KW - Mental illnesses and pharmacy KW - Pharmaceutical services in mental health KW - Polypharmacy and clinical pharmacy KW - Psychotropics and clinical pharmacy UR - https://link.springer.com/article/10.1007/s11096-023-01643-4 N2 - A large proportion of the world's disease burden is attributable to mental illnesses. Although effective interventions are available, many patients still have limited access to evidence-based treatments. Aside from access, treatment gaps, including inappropriate medication selection and monitoring, are also routinely recognised. Mental health clinical pharmacists can help address these gaps and enable patients to receive optimised pharmaceutical care, particularly appropriate medication selection and monitoring. The European Society of Clinical Pharmacy (ESCP) Special Interest Group on Mental Health was established to improve standardised service provision in mental health settings across Europe. The Special Interest Group identified significant barriers (predominantly associated with reimbursement and position within the multidisciplinary team) to effective pharmaceutical care amongst those with mental illnesses. This commentary presents recommendations to address these gaps through improved mental health clinical pharmacy service provision. ER -
STUHEC, Matej, M. HAHN, Ivana TAŠKOVÁ, I. BAYRAKTAR, I. FITZGERALD, L. MOLITSCHNIG, A. TATAREVIC, N. LINDNER, L. AGNOLETTO a F. DA COSTA. Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health. \textit{INTERNATIONAL JOURNAL OF CLINICAL PHARMACY}. NETHERLANDS: SPRINGER, 2023, roč.~45, č.~5, s.~1286-1292. ISSN~2210-7703. Dostupné z: https://dx.doi.org/10.1007/s11096-023-01643-4.
|